Basis of Presentation (Tables)

6 Months Ended

Jun. 30, 2025

Accounting Policies [Abstract]

Schedule of Indefinite-Lived Intangible Assets

U.S. Method Patent	13.4 years
Web Domain	Indefinite life
Trademark	Indefinite life

Schedule of Revenue Recognition

The Company’s revenues consisted of the following:

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2025		2024		2025		2024
Allergy Diagnostic Kit Sales	$	197,644	$	190,994	$	462,557	$	428,060
Integrated Service Program		263,628		160,448		426,130		287,452
Immunotherapy Treatment Sales		119,885		92,482		217,214		178,807
Clinical Study Revenue		-		-		89,100		-
Subscription Revenue		9,252		14,339		18,537		32,709
Shipping and handling		10,091		8,861		20,061		18,820
Training and Other Revenue		4,946		5,949		17,266		15,812
Total revenue	$	605,446	$	473,073	$	1,250,865	$	961,660